Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Chinese Patent Office
Express Scripts
Queensland Health
McKesson
Citi
Dow
Baxter
Fuji

Generated: June 18, 2018

DrugPatentWatch Database Preview

DANTRIUM Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Dantrium patents expire, and when can generic versions of Dantrium launch?

Dantrium is a drug marketed by Par Sterile Products and is included in two NDAs.

The generic ingredient in DANTRIUM is dantrolene sodium. There are five drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the dantrolene sodium profile page.
Drug patent expirations by year for DANTRIUM
Medical Subject Heading (MeSH) Categories for DANTRIUM
Synonyms for DANTRIUM
1-(((5-(4-Nitrophenyl)-2-furanyl)methylene)amino)-2,4-imidazolidinedione
1-(((E)-[5-(4-Nitrophenyl)-2-furyl]methylidene)amino)-2,4-imidazolidinedione #
1-((5-(4-Nitrophenyl)furfurylidene)amino)imidazolidine-2,4-dione, sodium salt
1-((5-(p-Nitrophenyl)furfurylidene)amino)hydantoin
1-((5-(p-nitrophenyl)furfurylidene)amino)hydantoin anion
1-((5-(p-Nitrophenyl)furfurylidene)amino)hydantoin sodium
1-((5-(p-Nitrophenyl)furfurylidene)amino)hydantoin sodium salt hydrate
1-({(1E)-[5-(4-nitrophenyl)furan-2-yl]methylidene}amino)imidazolidine-2,4-dione
1-({[5-(4-nitrophenyl)furan-2-yl]methylidene}amino)imidazolidine-2,4-dione
1-[(5--(p-Nitro-phenyl)-fur-furyl-idene)-amino]-hydan-toin sodium salt
1-[(5-[p-Nitrophenyl]-furfurylidene)amino]hydantoin
1-[(E)-[5-(4-nitrophenyl)furan-2-yl]methylideneamino]imidazolidine-2,4-dione
1-[[[5-(4-Io>>u+/-(1/2))-2-ss>>a<<>>u]NC(1/4)x>>u degrees +/->>u]-2,4-ssassosso paragraph signthornI feminine AAENI
1-[[[5-(4-Nitrophenyl)-2-furanyl]methylene]amino]-2,4-imidazolidinedione Sodium Salt Hemiheptahydrate
1-[[[5-(4-Nitrophenyl)-2-furanyl]methylene]amino]-2,4-imidazolinedione sodium salt
1-[[5-(p-Nitrophenyl)furfurylidene]amino]hydantoin
1-[5-(4-nitro-phenyl)-furan-2-ylmethyleneamino]-imidazolidine-2,4-dione
1-[5-(4-Nitrophenyl)furfurylideneamino]hydantoin Sodium Salt
1-{(5-{p-nitrophenyl}furfurylidene)-amino}hydantoin sodium
14663-23-1
2,4-Imidazolidinedione, 1-(((5-(4-nitrophenyl)-2-furanyl)methylene)amino)-
2,4-Imidazolidinedione, 1-(((5-(4-nitrophenyl)-2-furanyl)methylene)amino)-, sodium salt
2,4-Imidazolidinedione, 1-(((5-(4-nitrophenyl)-2-furanyl)methylene)amino)-, sodium salt, hydrate (2:7)
2,4-Imidazolidinedione, 1-[[[5-(4-nitrophenyl)-2-furanyl]methylene]amino]-
2,4-Imidazolidinedione, 1-[[[5-(4-nitrophenyl)-2-furanyl]methylene]amino]-, sodium salt, hydrate
24868-20-0
287M0347EV
28F0G1E0VF
2C14H9N4O5.2Na
2C14H9N4O5.2Na.7H2O
3-({[5-(4-nitrophenyl)furan-2-yl]methylidene}amino)-2,5-dioxoimidazolidin-1-ide
3-[(E)-[5-(4-nitrophenyl)furan-2-yl]methylideneamino]-5-oxo-4H-imidazol-2-olate
63D231
663D231
7261-97-4
A817527
AB00053743_02
AB0011237
AB00513823
AC-25752
AC1O7G8U
AC1O7GSO
AC1OC9NE
AKOS015895197
AKOS015895198
AKOS015902289
AKOS015963269
Ambap14663-23-1
anhydrous dantrolene sodium
B6329
BC215665
BCBcMAP01_000067
BDBM200293
BIDD:GT0187
BPBio1_000246
BRD-K81272440-001-02-6
BRD-K81272440-236-05-1
BRN 0705189
BSPBio_000222
BSPBio_001305
BSPBio_003074
C-22163
C06939
C07933
C14H10N4O5
C14H9N4O5.Na
CCG-204516
CCG-220291
CCG-221728
CCG-40324
CHEBI:184644
CHEBI:4317
CHEBI:4318
CHEBI:59697
CHEMBL1201288
CHEMBL928
cid_6604728
CPD000326766
CS-5234
D 9175
D02274
D02347
D0I8DD
D3996
Dantamacrin
Dantrium (TN)
Dantrium Intravenous
Dantrix
Dantrolen (TN)
dantrolene
Dantrolene (sodium salt)
Dantrolene (sodium)
Dantrolene (USAN/INN)
Dantrolene [USAN:BAN:INN]
Dantrolene [USAN:INN:BAN]
dantrolene anion
DANTROLENE SODIUM
Dantrolene Sodium (anhydrous)
Dantrolene sodium (USAN)
Dantrolene sodium [USAN:BAN:JAN]
Dantrolene sodium [USAN:USP:BAN:JAN]
Dantrolene sodium anhydrous
Dantrolene sodium hemiheptahydrate
Dantrolene Sodium Hydrate
Dantrolene sodium hydrate (JP17)
Dantrolene sodium salt
Dantrolene, Sodium Salt
dantrolene(1-)
Dantrolenesodium
Dantroleno
Dantroleno [INN-Spanish]
Dantrolenum
Dantrolenum [INN-Latin]
DB01219
disodium 3-[(E)-[5-(4-nitrophenyl)-2-furanyl]methylideneamino]-5-oxo-4H-imidazol-2-olate heptahydrate
disodium 3-[(E)-[5-(4-nitrophenyl)furan-2-yl]methylideneamino]-5-oxidanylidene-4H-imidazol-2-olate heptahydrate
disodium;1-[(E)-[5-(4-nitrophenyl)furan-2-yl]methylideneamino]imidazolidin-3-ide-2,4-dione;heptahydrate
EINECS 230-684-8
EINECS 238-706-8
EU-0100424
F 440
F-368
F-440
F64QU97QCR
FT-0082847
HMS1361B07
HMS1568L04
HMS1791B07
HMS1989B07
HMS2092N12
HMS2095L04
HMS3261E10
HMS3266G14
HMS3402B07
HMS502M20
HSDB 3050
HY-14657
Hydantoin, 1-((5-(p-nitrophenyl)furfurylidene)amino)-
Hydantoin, 1-((5-(p-nitrophenyl)furfurylidene)amino)-, sodium salt
Hydantoin, 1-((5-(p-nitrophenyl)furfurylidene)amino)-, sodium salt, hydrate (2:7)
I06-0335
I06-0336
I14-13402
IDI1_000898
IDI1_033775
J-015708
Lopac0_000424
LS-174074
LS-76264
LS-76265
MFCD00079130
MLS000859905
MLS002153441
MolPort-003-666-797
MolPort-006-069-178
NCGC00024622-02
NCGC00024622-03
NCGC00024622-04
NCGC00093847-01
NCGC00163132-01
NCGC00163402-01
NCGC00163402-02
NCGC00163402-03
NCGC00188950-01
NCGC00261109-01
NSC-758403
NSC758403
OZOMQRBLCMDCEG-VIZOYTHASA-N
Pharmakon1600-01503209
potassium 1-({[5-(4-nitrophenyl)furan-2-yl]methylidene}amino)-4-oxo-5H-imidazol-2-olate
Prestwick2_000291
Prestwick3_000291
R452
Ryanodex
SAM002703135
SBI-0050409.P003
SCHEMBL12417164
SCHEMBL2903719
SCHEMBL40893
SMR000326766
sodium 1-[(E)-{[5-(4-nitrophenyl)furan-2-yl]methylidene}amino]-4-oxo-5H-imidazol-2-olate
sodium 3-({[5-(4-nitrophenyl)furan-2-yl]methylidene}amino)-2,5-dioxoimidazolidin-1-ide
sodium 3-({[5-(4-nitrophenyl)furan-2-yl]methylidene}amino)-2,5-dioxoimidazolidin-1-ide--water (2/7)
sodium 3-[(E)-[5-(4-nitrophenyl)furan-2-yl]methylideneamino]-5-oxo-4H-imidazol-2-olate
Sodium dantrolene
Sodium, Dantrolene
Spectrum5_001752
SR-01000076241
SR-01000076241-1
ST51052737
Tox21_500424
TR-005822
UNII-287M0347EV
UNII-28F0G1E0VF
UNII-F64QU97QCR
ZINC7997966

US Patents and Regulatory Information for DANTRIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Par Sterile Products DANTRIUM dantrolene sodium CAPSULE;ORAL 017443-001 Approved Prior to Jan 1, 1982 AB RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Par Sterile Products DANTRIUM dantrolene sodium INJECTABLE;INJECTION 018264-001 Approved Prior to Jan 1, 1982 AP RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Par Sterile Products DANTRIUM dantrolene sodium CAPSULE;ORAL 017443-003 Approved Prior to Jan 1, 1982 AB RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Par Sterile Products DANTRIUM dantrolene sodium CAPSULE;ORAL 017443-002 Approved Prior to Jan 1, 1982 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Expired US Patents for DANTRIUM

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Par Sterile Products DANTRIUM dantrolene sodium INJECTABLE;INJECTION 018264-001 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Par Sterile Products DANTRIUM dantrolene sodium CAPSULE;ORAL 017443-001 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Par Sterile Products DANTRIUM dantrolene sodium CAPSULE;ORAL 017443-002 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Par Sterile Products DANTRIUM dantrolene sodium CAPSULE;ORAL 017443-003 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Chubb
Moodys
US Army
Merck
Deloitte
Cantor Fitzgerald
Baxter
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.